About Us
E3A Healthcare was founded in 2019 at the National University of Singapore, inspired by the very place where innovation began—the Bioengineering Building, known as "E3A." Fittingly, the name also reflects the dock number of the sailboat that served as our first office, symbolizing the spirit of resilience and ingenuity that drives our company forward.
At E3A Healthcare, we are on a mission to revolutionize women’s health with cutting-edge, AI-driven, non-invasive medical devices. By addressing critical gaps in care, we empower women to take charge of their health, transforming their quality of life and enabling them to thrive with confidence and vitality.
Where E3A was Established
Block E3A, Department of Biomedical Engineering, National University of Singapore
Our Very First Office
Dock E3A, Raffles Marina, Singapore
E3A Healthcare was born on a sailboat named Watermelon, docked at E3A Pier at Raffles Marina, Singapore. Serving as our first office, this humble and unconventional beginning symbolizes the boldness and resourcefulness that have shaped our mission to revolutionize women’s health through groundbreaking innovation.
Company Timeline
2024 and Beyond
Our Next Chapter of Growth
In 2024, E3A Healthcare entered a bold new phase, advancing medical technology and compassionate care. With expanded global collaborations, we are scaling our impact across Southeast Asia and North America, driving our mission to transform women’s health worldwide.
2023
Shaping the Future with Purposeful Innovation
In 2023, we took a major leap forward by acquiring Modoo, the leading brand in fetal heartbeat monitoring. This milestone expands our ability to meet a broader spectrum of needs, reinforcing our mission to redefine women’s health through cutting-edge, innovative care solutions.
2022
Redefining Care
In 2022, we secured Class II clearance for our smart jaundice meter and launched an innovative rental model for at-home monitoring. Partnering with 120+ hospitals, we’ve supported over 50,000 families, transforming access to newborn care.
2021
Pioneering Innovation
In 2021, we completed development and clinical trials for our first product, marking a major milestone in our journey. We also established our own ISO-13485-certified medical device manufacturing facility, enabling full in-house development and production of groundbreaking medical technologies.
2020
Expanding Reach and Expertise
In 2020, we began developing our first product—the smart newborn jaundice meter—while expanding our presence into Greater China by establishing offices in Hong Kong. This marked a pivotal step in combining innovation with regional expertise to drive our mission forward.
2019
Founding at NUS
In 2019, E3A Healthcare was founded at the National University of Singapore with a mission to close the innovation gap in women’s health. With a focus on addressing overlooked needs, we set out to create accessible, groundbreaking medical devices that empower women and redefine healthcare globally.